26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On April 7th, the City of Oakland released findings and determinations implementing the construction...
Read More >
In a positive development for non-union contractors, a federal judge has reaffirmed the traditional ...
Read More >
Dear Littler: A long-term San Francisco-based employee with our company is returning soon from mater...
Read More >
You expect your insurance carrier to provide coverage when a claim is made against your company. How...
Read More >
Looking for authoritative information about the latest developments and challenges the current crisi...
Read More >
When picking plan providers, you must have a rational process in place to that. There must be a vari...
Read More >